Physician profile
Blake A Seeker
NPI 1982224770
$1,184.18
in general payments reported to CMS, 2019-2025
17 companies · $960 in 2025
The $960 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $224 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $183.48 | 2024-2025 | Truclear, Ligasure |
| Pfizer INC. | $153.49 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $145.37 | 2024-2025 | Gemtesa, Myfembree |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $93.50 | 2025 | Myosure Tissue Removal Device |
| Dexcom, INC. | $82.99 | 2024-2025 | Dexcom G6 Transmitter |
| Millicent US INC | $57.09 | 2025 | Femlyv |
| Biogen, INC. | $51.98 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $47.66 | 2025 | |
| Coloplast Corp | $45.88 | 2025 | |
| Astellas Pharma US INC | $44.90 | 2024-2025 | Veozah |
| Boston Scientific Corporation | $36.46 | 2025 | Axonics |
| Abbvie INC. | $29.57 | 2025 | |
| Exeltis, USA INC. | $28.07 | 2025 | Slynd |
| Mayne Pharma Commercial LLC | $27.20 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $19.93 | 2024 | Bulkamid |
| Evofem Biosciences, INC. | $11.61 | 2025 | Phexxi, Solosec, Phexx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Seeker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.